Evidence map›Paper›PMID 38319469›Full record

ArticleCardiovascular drugs and therapy2024

Dapagliflozin for Atrial Fibrillation.

Na Li, Mihail G Chelu, Yochai Birnbaum

Open access · bronzeAbstract readEditorial
In one paragraph

Article in Cardiovascular drugs and therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Abnormal "Frontiers in cardiovascular medicine · 2026
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Na LiDepartment of Medicine (Section of Cardiovascular Research), Baylor College of Medicine, Houston, USA.
Mihail G CheluDepartment of Medicine (Section of Cardiology), Baylor College of Medicine, 7200 Cambridge Street, MS BCM620, Houston, TX, 77030, USA.
Yochai BirnbaumDepartment of Medicine (Section of Cardiology), Baylor College of Medicine, 7200 Cambridge Street, MS BCM620, Houston, TX, 77030, USA. ybirnbau@bcm.edu.ORCID 0000-0001-7653-6328
Baylor College of Medicine · US

Funding

The Role of Inflammasome in the Pathogenesis of Atrial FibrillationR01HL136389 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Na Li · 2017 to 2026
$5.6M
Cardiac fibroblast inflammasome and atrial myopathyR01HL163277 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI LI, NA · 2022 to 2025
$2.8M
FKBP5 AND CARDIAC ARRHYTHMOGENESISR01HL164838 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Na Li · 2024 to 2026
$1.7M
NHLBI NIH HHS R01 HL136389NHLBI NIH HHS R01 HL163277NHLBI NIH HHS R01 HL164838NIEHS NIH HHS R01HL163277Patient-Centered Outcomes Research Institute 2021C3- 24160
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Atrial FibrillationBenzhydryl CompoundsGlucosidesHumansBenzhydryl CompoundsdapagliflozinGlucosides

Identifiers

PMID38319469
PMCPMC11428186
OpenAlexW4391573680

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.